ABSTRACT
BACKGROUND: Many studies have concluded that cannabis use disorder (CUD) negatively influences outcomes in first-episode psychosis (FEP). However, few have taken into account the impact of concurrent misuse of other substances. METHODS: This 2-year, prospective, longitudinal study of FEP patients, aged between 18 and 30 years, admitted to early intervention programs in Montreal, Quebec, Canada, examined the specific influence of different substance use disorders (SUD) (alcohol, cannabis, cocaine, amphetamines) on service utilization, symptomatic and functional outcomes in FEP. RESULTS: Drugs and alcohol were associated with lower functioning, but drugs had a greater negative impact on most measures at 2-year follow-up. Half of CUD patients and more than 65% of cocaine or amphetamine abusers presented polysubstance use disorder (poly-SUD). The only group that deteriorated from years 1 to 2 (symptoms and functioning) were patients with persistent CUD alone. Outcome was worse in CUD than in the no-SUD group at 2 years. Cocaine, amphetamines and poly-SUD were associated with worse symptomatic and functional outcomes from the 1st year of treatment, persisting over time with higher service utilization (hospitalization). CONCLUSION: The negative impact attributed to CUD in previous studies could be partly attributed to methodological flaws, like including polysubstance abusers among cannabis misusers. However, our investigation confirmed the negative effect of CUD on outcome. Attention should be paid to persistent cannabis misusers, since their condition seems to worsen over time, and to cocaine and amphetamine misusers, in view of their poorer outcome early during follow-up and high service utilization.
Subject(s)
Alcohol-Related Disorders/complications , Amphetamine-Related Disorders/complications , Cocaine-Related Disorders/complications , Disease Progression , Marijuana Abuse/complications , Outcome Assessment, Health Care , Psychotic Disorders/etiology , Adolescent , Adult , Alcohol-Related Disorders/epidemiology , Alcohol-Related Disorders/therapy , Amphetamine-Related Disorders/epidemiology , Amphetamine-Related Disorders/therapy , Cocaine-Related Disorders/epidemiology , Cocaine-Related Disorders/therapy , Female , Humans , Longitudinal Studies , Male , Marijuana Abuse/epidemiology , Marijuana Abuse/therapy , Psychoses, Substance-Induced/epidemiology , Psychoses, Substance-Induced/etiology , Psychotic Disorders/epidemiology , Psychotic Disorders/therapy , Quebec/epidemiology , Young AdultABSTRACT
We present the design of a confocal microscope adapted for optical spectroscopy and imaging at cryogenic temperatures. This system is based on the existing approach of partly inserting the optical components of the microscope inside a helium-bath cryostat. It provides a spatial resolution approaching the diffraction limit with a mechanical stability allowing uninterrupted integration times exceeding 10 h and allows keeping track of a single emitter for unlimited periods of time. Furthermore, our design allows scanning the excitation spot and detection area independently of the sample position. This feature provides the means to perform probeless transport experiments on one-dimensional nanostructures. The scanning capabilities of this microscope are fully detailed and characterized using the photoluminescence of single nitrogen dyads at 4.5 K.